To Distinguish Itself From Proteomics Crowd, MelTec Visualizes and Maps the Toponome | GenomeWeb

Perhaps because studying the proteome has become a crowded endeavor, an East German startup called MelTec has set its eyes on a new “ome:” the toponome. Determining all the structural networks that proteins form within a single cell — MelTec’s description of the toponome — and how their composition changes at different stages, will be more meaningful for drug discovery than just looking at differences in protein expression levels over an average of many cells, according to Walter Schubert, the company’s founder and CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.